Tag Archive: investigator meetings

Jul 28 2011

Imaginary patients, Imaginary data, et Cetero, et Cetero…

The FDA recently issued a letter to a CRO based in Cary, NC, outlining serious violations at one of their facilities including “widespread falsification of dates and times in laboratory records… and the apparent manipulation of equilibration samples to meet predetermined acceptance criteria.”  This letter is a follow-up to two on-site audits, conducted as a …

Continue reading »

Jan 28 2011

How will Healthcare Reform Impact Your Next Investigator Meeting?

The new Healthcare reform legislation can be debated by Americans for days on end, but tucked in among all of the changes for Medicare beneficiaries, pre-existing conditions, and the effects on small business owners lays a provision that most layman would not even notice. This provision, however, has the attention of US drug and device manufacturers and cannot be ignored.

Jan 24 2011

Free Webinar – Planning Investigator Meetings

At 3:00 PM (Eastern) on Monday, 31 January 2011, Cato Research will host a free webinar  to discuss our process for selecting and partnering with investigator meeting planning vendors. We’ll be joined by Kim Howard, Vice President of TMP Meeting Services, who will share information on what makes the best meeting planning partner as well …

Continue reading »